Skip to main content
NIH funding notice PAR-18-546

Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development of Disorders of the Nervous System (UG3/UH3) - Clinical Trial Optional

Closed on March 3, 2020.

Posted
December 21, 2017
Close date
March 3, 2020
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

6 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $3,476,770 in first-year total cost, median $554,891.

Most frequent study sections

  1. Special Emphasis Panel[ZNS1 SRB-T (41)]2
  2. Special Emphasis Panel[ZNS1 SRB-T (31)]1
  3. Special Emphasis Panel[ZNS1 SRB-T (34)]1
  4. Special Emphasis Panel[ZNS1 SRB-T (37)]1
  5. Special Emphasis Panel[ZNS1 SRB-T (44)]1

Most frequent institutions

  1. DUKE UNIVERSITY1
  2. EMORY UNIVERSITY1
  3. MAYO CLINIC ROCHESTER1
  4. RBHS-ROBERT WOOD JOHNSON MEDICAL SCHOOL1
  5. UNIVERSITY OF PITTSBURGH AT PITTSBURGH1
Competing awards under PAR-18-546 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2021Small molecule mitochondria-targeted therapeutics for AD1UG3NS113776-01A1TRUSHINA, EUGENIAMAYO CLINIC ROCHESTER, MN$785,056ZNS1
2020RNA Targeted Drug Discovery and Development for Parkinson Disease1UG3NS116921-01DISNEY, MATTHEW DMOURADIAN, M. MARALRBHS-ROBERT WOOD JOHNSON MEDICAL SCHOOL, NJ$522,761ZNS1
2020Non-addictive Angiotensin AT2 inhibitors for neuropathic pain relief1UG3NS116929-01CHEREZOV, VADIMKATRITCH, VSEVOLODMAJUMDAR, SUSRUTASHEPHERD, ANDREW JOHNUNIVERSITY OF SOUTHERN CALIFORNIA, CA$483,858ZNS1
2020EP2 Antagonist Development for Post-seizure Cognitive Deficits1UG3NS113879-01DINGLEDINE, RAYMOND JGANESH, THOTAEMORY UNIVERSITY, GA$475,368ZNS1
2019Inhibitors of TrkB Signaling1UG3NS111708-01MCNAMARA, JAMES O.DUKE UNIVERSITY, NC$622,707ZNS1
2019New Glycinergic Modulators as Potent Painkillers without Negative Psychoactive Effects1UG3NS108978-01TANG, PEIXU, YANUNIVERSITY OF PITTSBURGH AT PITTSBURGH, PA$587,020ZNS1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.